(Q24242912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sally L. Collins

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

A Swanton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Kehoe

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

17 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

CD005343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy for epithelial ovarian cancer--role of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy in advanced ovarian cancer: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Pretherapeutic scalene lymph node biopsy in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant chemotherapy for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant chemotherapy in stage X ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Secondary surgical cytoreduction for advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Intervention debulking surgery in advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

The potential role of neoadjuvant chemotherapy in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

Timing of surgery and the role of cytoreductive chemotherapy in patients with advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005343.PUB2

7 January 2021

10.1002/14651858.CD005343.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943850%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference